Mercury is a well recognized health hazard and an environmental contaminant. Mercury is known to suppress immune responses, but the mechanisms responsible for this effect are still unclear. The aims of this study were to investigate the effect of mercury on immune parameters, such as hematology, lymphocyte phenotypes and cytokine gene expression. Male BALB/c mice were exposed continuously to 0, 0.3, 1.5, 7.5, or 37.5 ppm of mercury in drinking water for 14 days. Food and water consumption decreased in a dose-dependent manner in mice exposed to mercury. Body weight was reduced at the highest dose of mercury whereas the relative kidney and spleen weight were significantly increased. The dose-range of mercury used did not cause hepatotoxicity as indicated by circulating alanine aminotransferase and aspartate aminotransferase. Circulating blood leukocytes were elevated in mice treated with the highest dose of mercury. Single-cell splenocyte cultures were used to determine the effects of mercury treatment on mitogen-induced lymphocyte blastogenesis. Mercury at 1.5 ppm increased the PHA and LPS stimulation indices for T and B lymphocytes, respectively reflecting the observed decrease in basal splenocyte proliferation in mercury-treated mice. Exposure to 7.5 and 37.5 ppm of mercury decreased the CD8+ T lymphocyte population in thymus, whereas double positive CD4+/CD8+ and CD4+ thymocytes were not altered. Mercury ranging from 1.5 to 37.5 ppm dose-dependently decreased CD3+ T lymphocytes in spleen; both CD4+ and CD8+ single positive lymphocyte numbers were decreased. The population of CD45+ B lymphocytes was not changed. Mercury altered the expression of cytokines (tumor necrosis factor alpha;, interferon gamma;, interleukin-12), c-myc, and major histocompatibility complex II in various organs. Results indicated that decreases in T lymphocyte populations in immune organs and altered cytokine gene expression may contribute to the immunosuppressive effects of inorganic mercury.
The Toxicologist. Society of Toxicology 42nd Annual Meeting and ToxExpo, Cutting-Edge Science, Networking, New Perspectives, March 9-13, 2003, Salt Lake City, Utah
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.